MichaelGuerreraMD
Pediatric Hematology & Oncology • Fairfax, VAAssociate Professor, Pediatrics, G Washington University School of Medicine & Hlth Sci
Dr. Guerrera is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8081 Innovation Park Dr
765
Fairfax, VA 22031Phone+1 571-472-1717Fax+1 571-472-1718- Is this information wrong?
Education & Training
Children's National Medical Center/George Washington UniversityFellowship, Pediatric Hematology/Oncology, 1998 - 2001
University of ConnecticutResidency, Pediatrics, 1995 - 1998- Uconn School Of MedicineClass of 1995
Certifications & Licensure
VA State Medical License 2021 - 2024
DC State Medical License 1999 - 2024
MD State Medical License 2000 - 2024- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Top Doctor Northern Virginia Magazine, 2020
- Top Doctor Washingtonian, 2015-2017, 2019
- Physician of the Year National Hemophilia Foundation, 2018
- Join now to see all
Clinical Trials
- A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD) Start of enrollment: 2017 Dec 18
Roles: Principal Investigator
Publications & Presentations
PubMed
- 11 citationsReal-world cost estimates of initiating emicizumab in US patients with haemophilia A.Benjamin J. Samelson-Jones, Christine Guelcher, Jan G. Kuhn, Regina Butler, Gita Massey, Michael F. Guerrera, Leslie Raffini> ;Haemophilia. 2021 May 29
- 54 citationsReal-world use of emicizumab in patients with haemophilia A: Bleeding outcomes and surgical procedures.Isabella McCary, Christine Guelcher, Jan G. Kuhn, Regina Butler, Gita Massey, Michael F. Guerrera, Lance Ballester, Leslie Raffini> ;Haemophilia. 2020 Apr 20
- A 17-Year-Old Girl With Weight Loss and Elevated Inflammatory Markers.Keri Toner, Hemalatha Srinivasalu, Michael F. Guerrera, Kelley Shirron, Anjum Bandarkar, Carrie Diamond, Binny Chokshi> ;Pediatrics. 2018 Nov 1
- Join now to see all
Abstracts/Posters
- Peri-Procedural Management and Outcomes of Patients with Hemophilia on Emicizumab ProphylaxisMichael F. Guerrera, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Real-World Use of Emicizumab in Patients with Hemophilia with and without InhibitorsMichael F. Guerrera, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Hospital Affiliations
Children's National HospitalWashington, District of Columbia
Inova Fairfax Medical CampusFalls Church, Virginia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
